Pro-angiogenic role of MMP-9 in invasion and metastasis of gastric cancer

doi: 10.18081/ajbm/2333-5106/014-03/122-133
"Research Article"

American Journal of BioMedicine  Volume 3, Issue 3, pages 122-133, March 2015

Tsan Chao; Chi Ming Yang; Po-Chieh Guo; Chiung-Wen Han; Huei Chen


Matrix metalloproteinases (MMPs) have been regarded as major critical molecules assisting tumor cells during metastasis. From the earliest work on MMPs in cancer, there has been a clear connection between MMPs, ECM degradation and cancer cell invasion. This study investigated the original links between MMP-9 and gastric cancer invasion. A synthetic MMP-9 inhibitor (MMI270) administered in both wild type and MMP-9-deficient nude mice, since in general the development of normal vasculature in MMP-9-deficient mice does not show any significant abnormalities. Mechanistically, the findings confirmed that MMP-9 inhibition diminishes neovascularization of metastases. Altogether, these findings demonstrate that MMP-9 contributes to tumor-induced angiogenesis and that tumor-associated inflammatory cells provide the major source of the proteinase. 

Keywords: MMP-9; Gastric cancer; Nude mice; Angiogenesis

Limited Access             Full Text-PDF            Cited By Links


1. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumorhost cell communication. Differentiation 2002;70:561–573. [PubMed]

2. Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis treatment and follow-up; European Society for Medical Oncology and others (2013). [View Article]

3. Stomach cancer incidence statistics; Cancer Research UK. [View Article]

4. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467-77. [PubMed]

5. Axon A. Symptoms and diagnosis of gastric cancer at early curable stage. Best Pract Res Clin Gastroenterol 2006; 20(4):697-708. [PubMed]

6. Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther 2014;40(3):250-60. [PubMed]

7. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986; 46 1–7. [PubMed]

8. Lochter A, Sternlicht MD, Werb Z, Bissell MJ. The significance of matrix metalloproteinases during early stages of tumor progression. Ann N Y Acad Sci 1998; 857:180–193. [PubMed]

9. Yousif NG. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Cell Biol Int 2014;38(1):85-91. [PubMed]

10. Kerkela E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol 2003;12:109–125. [PubMed]

11. Jumper C, Cobos E, Lox C. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med 2004;98:173–177. [PubMed]

12. Aoudjit F, Masure S, Opdenakker G, Potworski EF, St-Pierre Y. Gelatinaser B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer 1990;82:743–747. [PubMed]

13. Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA, Lakka SS. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 2005;4:1399–1408. [PubMed]

14. London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. Cancer Gene Ther 2003;10: 823–832. [PubMed]

15. Vande B, Asosingh K, Allegaert V, et al. Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor. Leukemia 2004;18: 976–982. [PubMed]

16. Allport JR, Lim YC, Shipley JM, et al. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J Leukoc Biol 2002;71: 821–828. [PubMed]

17. Itoh T, Tanioka M, Matsuda H, et al. Experimental metastasis is suppressed in MMP-9- deficient mice. Clinical & Experimental Metastasis 1999;17: 177–181. [PubMed]

18. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006; 231: 20–27. [PubMed]

19. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004;167: 223–229. [PubMed]

20. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005;169: 681–691. [PubMed]


Print Friendly, PDF & Email